|
MIA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.277900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.763000E-04 |
| Normal-vs-Stage2 |
2.084500E-02 |
| Normal-vs-Stage3 |
8.518600E-01 |
| Normal-vs-Stage4 |
3.963800E-01 |
| Stage1-vs-Stage2 |
5.863400E-01 |
| Stage1-vs-Stage3 |
1.694020E-02 |
| Stage1-vs-Stage4 |
5.032600E-01 |
| Stage2-vs-Stage3 |
1.196620E-01 |
| Stage2-vs-Stage4 |
6.696000E-01 |
| Stage3-vs-Stage4 |
4.617200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.378200E-03 |
| Normal-vs-AfricanAmerican |
1.622430E-02 |
| Normal-vs-Asian |
1.511180E-01 |
| Caucasian-vs-AfricanAmerican |
8.888200E-01 |
| Caucasian-vs-Asian |
9.815400E-01 |
| AfricanAmerican-vs-Asian |
9.383000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.567399999995E-05 |
| Normal-vs-Female |
8.506000E-01 |
| Male-vs-Female |
8.424400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.636400E-02 |
| Normal-vs-Extreme_Weight |
3.66470000000563E-05 |
| Normal-vs-Obese |
1.998040E-01 |
| Normal-vs-Extreme_Obese |
2.740100E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.463160E-01 |
| Normal_Weight-vs-Obese |
5.738400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.334200E-01 |
| Extreme_Weight-vs-Obese |
1.726080E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.475800E-01 |
| Obese-vs-Extreme_Obese |
1.569410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.208000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.192560E-01 |
| Normal-vs-Age(61-80Yrs) |
1.012380E-04 |
| Normal-vs-Age(81-100Yrs) |
6.358200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.531990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.300280E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.375860E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.439920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.545500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.773400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.08509999999329E-05 |
| Normal-VS-Type2 PRCC |
1.909650E-01 |
| Normal-VS-KIRP CIMP |
1.997590E-01 |
| Normal-VS-Unclassified PRCC |
4.146200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.754100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.191800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.097800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.223900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.905400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.140300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.138910E-03 |
| Normal-vs-N1 |
3.269600E-01 |
| Normal-vs-N2 |
8.298600E-01 |
| N0-vs-N1 |
1.600130E-02 |
| N0-vs-N2 |
1.490420E-01 |
| N1-vs-N2 |
8.261200E-01 |
|
|
